Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING

MIPE for Pilonidal Disease

NCT03772873 · View on ClinicalTrials.gov ↗

Study Summary

Pilonidal disease often presents as a chronic, relapsing condition. A variety of procedures are used in the management of pilonidal disease, with varying degrees of morbidity, disease-free interval, and long-term success. In patients with new-onset or recurrent pilonidal disease, the investigators aim to address how minimally invasive trephine excision compares to other surgical procedures in terms of short- and long-term clinical outcomes and patient satisfaction. In the absence of a gold standard surgical procedure, surgeon preference will help dictate the management of pilonidal disease. For many surgeons, this means a variation on open excision for pilonidal disease failing conservative management. However, outcomes for minimally invasive pilonidal excision (MIPE) as initially described by Gips and forthcoming Lipskar et al., are likely to alter management of the disease (Gips, 2008). The investigators wish to assess patient and surgeon satisfaction with MIPE, and short-term outcomes.

Interventions

  • PROCEDURE minimally invasive pilonidal excision

Study Locations (10)

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago
  • Advocate Health Center — Park Ridge

Texas

  • Children's Medical Center Dallas — Dallas
  • Texas Children's Hospital — Houston

Maine

  • Maine Medical Center — Portland

Maryland

  • University of Maryland Medical Center — Baltimore

New York

  • Cohen Children's Medical Center — New Hyde Park

Ohio

  • Dayton Children's Hospital — Dayton

Pennsylvania

  • Lehigh Valley Reilly Children's Hospital — Allentown

Tennessee

  • LeBonheur Children's Hospital — Memphis

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2019-01-01
Est. Completion 2026-06-01

Sponsor

Northwell Health

371 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03772873

The ClinicalTrials.gov registry entry for NCT03772873 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 371 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 10 conditions, with Pilonidal Disease appearing as the primary indexed condition, and to 1 intervention — of which minimally invasive pilonidal excision is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03772873 reports 10 study locations spanning 8 distinct geographic areas — top geographies include Illinois, Texas, Maine. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03772873 about?

NCT03772873 is a clinical study titled "MIPE for Pilonidal Disease". Pilonidal disease often presents as a chronic, relapsing condition. A variety of procedures are used in the management of pilonidal disease, with varying degrees of morbidity, disease-free interval, and long-term success. In patients with new-onset or recurrent pilonidal disease, the investigators a...

What is the current status of trial NCT03772873?

This trial is currently active not recruiting. The enrollment target is 151 participants. The study started on 2019-01-01. Estimated completion is 2026-06-01.

What conditions does trial NCT03772873 study?

This clinical trial studies the following conditions: Pilonidal Disease, Pilonidal Cyst/Fistula, Pilonidal Sinus Without Abscess, Pilonidal Cyst Without Abscess, Pilonidal Cyst and Sinus Without Abscess. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03772873?

The interventions under investigation include: minimally invasive pilonidal excision (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03772873?

This trial is sponsored by Northwell Health, which has 371 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03772873 being conducted?

This trial has 10 study locations across Illinois, Maine, Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial